Blood Routine Test Parameters Score, a Novel Predictor of Adverse Outcomes of Coronary Artery Disease Patients with or without Diabetes Who Underwent Percutaneous Coronary Intervention: A Retrospective Cohort Study
Jian Zhang,Ying-Ying Zheng,Ting-Ting Wu,Xiang Ma,Yi-Tong Ma,Xiang Xie,Bao-Peng Tang
DOI: https://doi.org/10.1021/acsomega.1c03990
IF: 4.1
2021-11-29
ACS Omega
Abstract:BACKGROUND: In this study, we developed a novel risk score named the blood routine test parameters (BRTP) score to predict the clinical outcomes in coronary artery disease (CAD) patients who had undergone percutaneous coronary intervention (PCI).METHODS: There were 6049 patients with CAD after PCI enrolled in CORFCHD-PCI from January 2008 to December 2016. We divided these patients into two groups according to diabetes (diabetic group, <i>n</i> = 3809, and nondiabetic group, <i>n</i> = 2240). During a follow-up time of 35.9 ± 22.6 months, we compared the incidences of all-cause mortality (ACM) and cardiac mortality (CM), which were assigned as the primary outcomes between patients with a high BRTP score (≥5 points) and those with a low BRTP score (<5 points).RESULTS: We found that the BRTP score independently predicted the risk for ACM and CM in both diabetic patients [ACM, hazard risk (HR) = 1.748 (95% confidence interval (CI): 1.186-2.575), <i>P</i> = 0.005; CM, HR = 1.728 (95% CI: 1.120-2.667), <i>P</i> = 0.014] and nondiabetic patients [ACM, HR = 1.682 (95% CI: 1.208-2.340), <i>P</i> = 0.002; CM, HR = 1.718 (95% CI: 1.188-2.484), <i>P</i> = 0.004]. However, the BRTP score was found to be an independent predictor for major adverse cardiovascular event (MACE) and major adverse cardiovascular and cerebrovascular event (MACCE) in diabetic patients [MACE, HR = 1.366 (95% CI: 1.076-1.734), <i>P</i> = 0.010; MACCE, HR = 1.330 (95% CI: 1.035-1.710), <i>P</i> = 0.026] but not in nondiabetic patients [MACE, HR = 1.241 (95% CI: 0.994-1.549), <i>P</i> = 0.056; MACCE, HR = 1.238 (95% CI: 0.981-1.562), <i>P</i> = 0.072].CONCLUSIONS: This study suggests that the BRTP score is an independent and novel predictor of mortality in CAD patients who had undergone PCI, especially in patients with comorbidity of diabetes.TRIAL REGISTRATION: ChiCTR-ROC-16010153. Registered 14, December, 2016.
chemistry, multidisciplinary